Silverback Therapeutics Competitors and Similar CompaniesClear all
Silverback Therapeutics's competitors and similar companies include Zymeworks.
 Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | |
Founding Date | Founding Date 2016 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ | Locations Vancouver, CA HQ Seattle, US |
Employees | Employees 9067% increase | Employees 45519% increase |
Valuation ($) | Valuation ($) 550.4 m | Valuation ($) 973.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.3m (FY, 2022) | Revenue (est.) $106m (FY, 2025) |
Net income | Net income ($34.7m) (FY, 2022) | Net income ($81.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 211m | Total funding raised $ 125.9m |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company